| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer
|
Saito, Kei
|
|
2018
|
35 |
7 |
p. 1-8
|
artikel
|
| 2 |
Clinical and Histopathologic Correlates and Management Strategies for Inflammatory Myofibroblastic tumor of the lung. A case series and review of the literature
|
Sagar, Ala Eddin S.
|
|
2018
|
35 |
7 |
p. 1-10
|
artikel
|
| 3 |
Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center
|
Tiu, Andrew C.
|
|
2018
|
35 |
7 |
p. 1-10
|
artikel
|
| 4 |
Discontinuation of hormone therapy for elderly breast cancer patients after hypofractionated whole-breast radiotherapy
|
Dispinzieri, Michela
|
|
2018
|
35 |
7 |
p. 1-10
|
artikel
|
| 5 |
ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer
|
Villalobos, Matthias
|
|
2018
|
35 |
7 |
p. 1-8
|
artikel
|
| 6 |
Generalizability of clinical trials of advanced melanoma in the real-world, population-based setting
|
Sam, Davis
|
|
2018
|
35 |
7 |
p. 1-8
|
artikel
|
| 7 |
Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer
|
Skarmoutsos, Ioannis
|
|
2018
|
35 |
7 |
p. 1-6
|
artikel
|
| 8 |
Incidence and outcome of second malignancies in patients with chronic myeloid leukemia during treatment with tyrosine kinase inhibitors
|
Nakazato, Tomonori
|
|
2018
|
35 |
7 |
p. 1-8
|
artikel
|
| 9 |
Is there a role for immunotherapy in malignant pleural mesothelioma?
|
Tartarone, Alfredo
|
|
2018
|
35 |
7 |
p. 1-5
|
artikel
|
| 10 |
MGMT promoter methylation is not correlated with integrin expression in malignant gliomas: clarifying recent clinical trial results
|
Schnell, Oliver
|
|
2018
|
35 |
7 |
p. 1-7
|
artikel
|
| 11 |
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping
|
Papaxoinis, George
|
|
2018
|
35 |
7 |
p. 1-13
|
artikel
|
| 12 |
Prognosis of elderly gastric cancer patients after surgery: a nomogram to predict survival
|
Roberto, Michela
|
|
2018
|
35 |
7 |
p. 1-9
|
artikel
|
| 13 |
Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer
|
Farias, Albert J.
|
|
2018
|
35 |
7 |
p. 1-11
|
artikel
|
| 14 |
Simultaneous PET/MRI in assessing the response to chemo/radiotherapy in head and neck carcinoma: initial experience
|
Romeo, Valeria
|
|
2018
|
35 |
7 |
p. 1-6
|
artikel
|
| 15 |
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
|
Nishimoto, Koji
|
|
2018
|
35 |
7 |
p. 1-7
|
artikel
|
| 16 |
Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma
|
Konishi, Yuji
|
|
2018
|
35 |
7 |
p. 1-8
|
artikel
|
| 17 |
α-Viniferin activates autophagic apoptosis and cell death by reducing glucocorticoid receptor expression in castration-resistant prostate cancer cells
|
Cheng, Kejun
|
|
2018
|
35 |
7 |
p. 1-11
|
artikel
|
Tijdschrift beschrijving